Wellness Index Report, an independent wellness ratings and education platform, has published a new Inside the Index feature spotlighting Nefense, a company helping redefine modern nasal wellness through innovative hypochlorous acid (HOCl) and xylitol-based products. The report examines growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care.
According to the Wellness Index Report, the feature reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. The report highlights Nefense's doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to over-the-counter sprays, formulated under the direction of Dr. Richard Downs, DDS.
The recognition comes at a time when consumers are increasingly seeking non-pharmaceutical options for respiratory wellness. Nefense's products, which include nasal sprays and rinses, are designed to support the body's natural defense mechanisms without the side effects associated with some medicated sprays. The Inside the Index feature provides an in-depth analysis of how Nefense's approach aligns with current scientific understanding of nasal health.
Wellness Index Report, founded by Lindsay O'Neill-O’Keefe, aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. The platform's Inside the Index editorial series highlights companies, practitioners, and technologies shaping the future of wellness and longevity.
For more details, the full announcement is available on Newsworthy.ai.
